Combined inhibition of BRAF and MEK in melanoma patients

Lancet Oncol. 2014 Aug;15(9):908-10. doi: 10.1016/S1470-2045(14)70331-6. Epub 2014 Jul 15.
No abstract available

Publication types

  • Comment

MeSH terms

  • Azetidines / administration & dosage*
  • Female
  • Humans
  • Indoles / administration & dosage*
  • Male
  • Melanoma / drug therapy*
  • Piperidines / administration & dosage*
  • Proto-Oncogene Proteins B-raf / drug effects*
  • Skin Neoplasms / drug therapy*
  • Sulfonamides / administration & dosage*
  • Vemurafenib

Substances

  • Azetidines
  • Indoles
  • Piperidines
  • Sulfonamides
  • Vemurafenib
  • Proto-Oncogene Proteins B-raf
  • cobimetinib